Morgan Stanley’s Nobilis Health Corp. HLTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-11,245
| Closed | -$1K | – | 6910 |
|
|
2019
Q2 | $1K | Sell |
11,245
-234
| -2% | -$46 | ﹤0.01% | 6618 |
|
|
2019
Q1 | $5K | Sell |
11,479
-109
| -0.9% | -$45 | ﹤0.01% | 6343 |
|
|
2018
Q4 | $5K | Sell |
11,588
-16,154
| -58% | -$9.52K | ﹤0.01% | 6319 |
|
|
2018
Q3 | $28K | Buy |
27,742
+1,131
| +4% | +$1.11K | ﹤0.01% | 6051 |
|
|
2018
Q2 | $32K | Sell |
26,611
-2,611
| -9% | -$3.62K | ﹤0.01% | 6031 |
|
|
2018
Q1 | $48K | Buy |
29,222
+377
| +1% | +$547 | ﹤0.01% | 5896 |
|
|
2017
Q4 | $39K | Sell |
28,845
-3,559
| -11% | -$4.91K | ﹤0.01% | 5897 |
|
|
2017
Q3 | $49K | Sell |
32,404
-54,346
| -63% | -$85.9K | ﹤0.01% | 5789 |
|
|
2017
Q2 | $165K | Sell |
86,750
-16,331
| -16% | -$24.7K | ﹤0.01% | 5435 |
|
|
2017
Q1 | $175K | Sell |
103,081
-72,202
| -41% | -$150K | ﹤0.01% | 5382 |
|
|
2016
Q4 | $368K | Buy |
175,283
+156,056
| +812% | +$425K | ﹤0.01% | 5090 |
|
|
2016
Q3 | $65K | Sell |
19,227
-18,173
| -49% | -$54.6K | ﹤0.01% | 5484 |
|
|
2016
Q2 | $83K | Sell |
37,400
-11,300
| -23% | -$36.7K | ﹤0.01% | 5325 |
|
|
2016
Q1 | $152K | Buy |
48,700
+13,596
| +39% | +$35.2K | ﹤0.01% | 5124 |
|
|
2015
Q4 | $99K | Buy |
35,104
+3,467
| +11% | +$11.1K | ﹤0.01% | 5415 |
|
|
2015
Q3 | $165K | Buy |
31,637
+21,022
| +198% | +$121K | ﹤0.01% | 5183 |
|
|
2015
Q2 | $72K | Buy |
+10,615
| New | +$75.3K | ﹤0.01% | 5735 |
|
Other funds holding HLTH
Morgan Stanley's HLTH Position: Q3 2019 in Review
Morgan Stanley sold out of Nobilis Health Corp. (HLTH) in Q3 2019, closing a stake of 11,245 shares — an estimated $1K sold.
Morgan Stanley first reported a position in HLTH in Q2 2015 and held it in 17 quarters. The position peaked at $368K in Q4 2016. 3 funds tracked by Wall St. Rank hold HLTH as of Q3 2019.
- Morgan Stanley reported no remaining Nobilis Health Corp. position as of Q3 2019 after selling out during the quarter.
- Morgan Stanley sold 11,245 Nobilis Health Corp. shares in Q3 2019, an estimated $1K.
- Morgan Stanley first reported a position in Nobilis Health Corp. in Q2 2015 and held it in 17 quarters.
- Morgan Stanley's Nobilis Health Corp. position peaked at $368K in Q4 2016.
- 3 funds tracked by Wall St. Rank held Nobilis Health Corp. as of Q3 2019.
Based on Morgan Stanley's 13F filing for Q3 2019, filed 14 Nov 2019.